IBA Molecular finds buyer for Canadian siteBy AuntMinnieEurope.com staff writers
July 6, 2012 -- Radiopharmaceutical provider IBA Molecular has found a buyer for a Canadian PET radiopharmacy.
The sale was prompted by IBA's decision to form IBA Molecular through a joint venture deal with SK Capital Partners. For legal reasons, IBA Molecular operations in Canada could not be included in the new venture.
In its place, IBA has signed a letter of intent to sell its shares in Pharmalogic PET Services of Montreal for approximately 10.9 million euros ($13.9 million U.S.) to a Canadian private equity firm.
The transaction could close within the next 60 days and result in a profit of approximately 9 million euros ($11.2 million U.S.) for IBA.
Copyright © 2012 AuntMinnieEurope.com
Last Updated 7/6/2012 9:31:37 AM